FDA accepts Dr. Reddy's biosimilar abatacept application for review Feb 20, 2026 10:57AM
Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug Aug 20, 2024 02:53PM
Dr. Reddys Labs (RDY) Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar Jul 29, 2024 11:55AM